久久久久免费_精品国产乱码久久久久久久软件_欧美一区亚洲一区_国产一区二区三区高清在线观看_欧美日在线观看_成人网av

美國伯樂 BIO-RAD  
Bio-Rad公司總部設在美國加里福尼亞州的Hercules，在全球有30多家全資子公司，服務于全球超過85,000家科研院所，生物技術和制藥公司，和臨床實驗室。
　公司自1952年成立以來，在50多年中為臨床診斷和生命科學研究市場提供了廣泛的新型產品和服務，始終居于科學發現的中心地位。Bio-Rad現今利用多種技術制造并生產了幾千種產品，這些技術包括蛋白質組學、生物信息學、電泳、成像、免疫測定、層析、微生物學和基因轉移。根據產品的不同，公司下設三大部門，它們是生命科學部，臨床診斷部和工業材料部，產品種類達6000余種。主要產品有蛋白組研究產品、層析儀與填料、蛋白質和核酸電泳產品、基因槍與電穿孔儀、定量基因擴增儀、圖像分析系統、激光共聚焦掃描顯微鏡、酶標儀和洗板機系列、食品檢測儀器與試劑、糖化血紅蛋白檢測系列產品、質控系統、毒物檢測產品、血液病毒檢測產品等。

Bio-Rad Laboratories has played a leading role in the advancement of scientific discovery for over 50 years by providing a broad range of innovative tools and services to the life science research and clinical diagnostics markets. Founded in 1952, Bio-Rad has a global team of more than 6,500 employees and serves more than 85,000 research and industry customers worldwide through its global network of operations. Throughout its existence, Bio-Rad has built strong customer relationships that advance scientific research and development efforts and support the introduction of new technology used in the growing fields of genomics, proteomics, drug discovery, food safety, medical diagnostics, and more.

Life Science Group:
Bio-Rad's Life Science Group develops, manufactures, and markets a wide range of laboratory instruments, apparatus, and consumables used for research in functional genomics, proteomics, and food safety. The group ranks among the top 5 life science companies worldwide, and maintains a solid reputation for quality, innovation, and commitment to its customers. Bio-Rad's life science products are based on technologies used to separate, purify, analyze, identify, and amplify biological materials such as proteins and nucleic acids. Some of these technologies include electrophoresis, imaging, multiplex immunoassay, chromatography, microbiology, bioinformatics, protein function analysis, transfection, amplification, and real-time PCR. Researchers in laboratories throughout the world rely on Bio-Rad's products.

Clinical Diagnostics Group:
Clinical Diagnostics develops, manufactures, sells, and supports a large portfolio of products for medical screening and diagnostics. Bio-Rad is the leading specialty diagnostics company in the world and its products are recognized as the gold standard for diabetes monitoring and quality control (QC) systems. The company is also well known for its blood virus testing and detection, blood typing, autoimmune and genetic disorders testing, and internet-based software products. Bio-Rad's clinical diagnostics products incorporate a broad range of technologies used to detect, identify, and quantify substances in bodily fluids and tissues. The results are used as aids to support medical diagnosis, detection, evaluation, and the 
Bio-Rad was founded in 1952 by David and Alice Schwartz, who remain actively involved in the company today. David Schwartz is Chairman of the Board and Alice is a director. Their son Norman Schwartz, with the company since 1974, is CEO and president.

The name "Bio-Rad" is based on the words "biochemicals and radiochemicals," which described the company's first offerings. However, instead of calling the company "Biochemical-Radiochemical Laboratories," the founders shortened it to simply Bio-Rad Laboratories.

For more than 50 years, Bio-Rad has retained the entrepreneurial spirit of its early days. Its founders launched the company in a Quonset hut in West Berkeley, California, and developed their first product, tobacco mosaic virus (TMV). Preparing TMV was a laborious task and the founders believed that providing it in a ready-to-use format would save scientists valuable time and effort, allowing them to focus on their research.

Although TMV was not the success envisioned, the seed was planted and Bio-Rad began its charter to accelerate scientific discovery processes by providing products and tools for researchers.

In the 1950s, Bio-Rad introduced the first analytical grade ion exchange resins for laboratory research applications, launching the company's Life Science Group. In 1957 Bio-Rad incorporated and in 1958 relocated its headquarters to Richmond, California. By 1966 the company sold its stock to the public and expanded internationally with its first overseas office in Germany.

Bio-Rad's early success with ion exchange resin products led to inquiries from physicians and hospital pathologists seeking a more reliable method for determining thyroid function. In conjunction with the medical community, Bio-Rad introduced the T-4 (thyroxine) thyroid test in 1967, the first commercially available test to accurately determine thyroid function. By the early 1970s Bio-Rad had developed tests for a variety of other medical conditions including cardiovascular disease, lead poisoning, and anemia, paving the way for the formation of the company's Clinical Diagnostics Group.

During the 1970s Bio-Rad entered the electrophoresis market with reagents, systems, and equipment, and today the company is a worldwide market leader in electrophoresis products. Bio-Rad's advancements in electrophoresis put the company at the forefront of unlocking the secrets of life contained in DNA and determining how genetic information translates into living organisms.

Over the years, Bio-Rad has evolved into a global enterprise that manufactures and distributes a broad range of products around the world. In 1975 Bio-Rad entered the quality controls market with the acquisition of Environmental Chemical Specialties, and today Bio-Rad is the number one supplier of quality controls worldwide.

In 1997 Bio-Rad launched its Biotechnology Explorer science educational program, giving high school and college students the opportunity to learn how real-world methods and applications work on instruments used in laboratories today.

The 1999 acquisition of Pasteur Sanofi Diagnostics, based in France, further broadened Bio-Rad's offerings with products for blood virus testing (HIV and hepatitis), microbiology and autoimmunity testing products, and the notable introduction of its bovine spongiform encephalopathy (BSE or "mad cow") test in 2000.

Today, Bio-Rad products are used in hospitals, universities, major research institutions, biotechnology companies, reference laboratories, pharmaceutical firms, and classrooms around the world. Bio-Rad's key competencies include separation, purification, and analysis, and the company is a leader in electrophoresis, protein assays, gel image analysis, quality controls, diabetes monitoring, autoimmune testing, blood typing, and BSE and chronic wasting disease testing.

The company's open-door style of leadership and entrepreneurial spirit inspires its employees, who are encouraged to develop new ideas. As a result Bio-Rad continues to thrive and plays a leading role in the advancement of scientific discovery, helping people live longer, healthier lives.